Published April 15, 2020
| Version v1
Journal article
Open
REMDESIVIR AND COVID-19
Authors/Creators
- 1. Department of Surgery, Faculty of Medicine, University of Colombo, Sri Lanka.
- 2. Department of Zoology and Environment Sciences, Faculty of Science, University of Colombo, Sri Lanka.
- 3. Nawaloka Hospital Research and Education Foundation, Nawaloka Hospitals, Colombo, Sri Lanka.
Description
The SARS-CoV-2 virus was first encountered in Wuhan, China in December 2019. At the present time, coronavirus disease 2019 (Covid-19) affects more than 170 countries. Several groups are carrying out intense research on drugs and vaccines to treat or prevent Covid-19. We have outlined aspects relating to Remdesivir, in treating RNA viral infections and its potential role in controlling SARS-Cov-2 infections.
Files
74.pdf
Files
(263.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:dd5c6b6a004e69128962a02305e495c2
|
263.0 kB | Preview Download |